SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Business
Genentech Dumps Another $650M in New Haven Biotech Arvinas
Arvinas expanded an ongoing licensing deal with Genentech.
November 15, 2017
 · 
3 min read
 · 
Mark Terry
Roche Could Take a $500M Hit Over Patent Losses
Deals
Run by Former Genentech Employees, Bay Area’s Denali Seeks $100M IPO
Denali plans to make a $100M IPO under the symbol DNLI.
November 14, 2017
 · 
2 min read
 · 
Mark Terry
FDA
FDA Approves Genentech’s Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease
People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option.
November 6, 2017
 · 
2 min read
 · 
Alex Keown
Business
Layoffs in California: Amgen to Slash 200 R&D Jobs, Genentech to Cut 130
It’s not uncommon for companies to announce layoffs in the final months of the year.
November 6, 2017
 · 
2 min read
 · 
Mark Terry
Genentech Grows on Promise of 70+ Drug Approvals
Job Trends
Genentech Grows Manufacturing and Looks to the Future
October 11, 2017
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech’s $6 Billion Best-Seller
September 15, 2017
 · 
3 min read
Job Trends
Why 23andMe Quietly Recruited Genentech Scientists
September 12, 2017
 · 
1 min read
Genentech Grows on Promise of 70+ Drug Approvals
Drug Development
Genentech’s Macular Degeneration Candidate Flunks Phase III Study
September 8, 2017
 · 
2 min read
Policy
Bristol-Myers Squibb Slaps Lawsuit On Biotech Pioneer Genentech Over Cancer Immunotherapy Patents
July 27, 2017
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
Speedy Review for Genentech’s OCREVUS, Action Date December 28
June 28, 2016
 · 
7 min read
Business
Epizyme, Genentech Join Forces for Tazemetostat and Tecentriq Trial in Non-Hodgkin Lymphoma
June 23, 2016
 · 
5 min read
Drug Development
Phase III Study Shows Genentech’s Actemra (Tocilizumab) Maintained Steroid-Free Remission In People With Giant Cell Arteritis (GCA)
June 6, 2016
 · 
6 min read
Drug Development
Genentech’s Arthritis Med Actemra Successful In Late-Stage Study in Rare Artery Inflammation
June 6, 2016
 · 
7 min read
Business
Evotec AG Extends Integrated Drug Discovery Alliance With Genentech
May 24, 2016
 · 
3 min read
Policy
Another Healthcare Provider Accuses Genentech of Fudging the Amount of Herceptin in Each Vial
May 23, 2016
 · 
1 min read
Drug Development
Phase III Study Of Genentech’s Alecensa (Alectinib) Showed Superior Efficacy Versus Crizotinib In Japanese People With A Specific Type Of Lung Cancer
May 19, 2016
 · 
8 min read
Pharm Country
Stand Up To Cancer And Genentech Join Forces Through “Be The Breakthrough” Campaign
May 4, 2016
 · 
4 min read
Drug Development
Genentech Highlights Personalized Medicines And Cancer Immunotherapies At 2016 ASCO Annual Meeting
May 3, 2016
 · 
1 min read
Drug Development
Genentech To Present New Data At American Academy of Neurology Showing Superior Efficacy Of Investigational Medicine Ocrelizumab Versus Comparators On Disease Activity And Progression In Two Forms Of Multiple Sclerosis
April 13, 2016
 · 
8 min read
Load More